Group items tagged

Studies indicate that those who died of Ebola have some common symptoms, which could provide a clue as to why some people survive the deadly disease.

This report studies the global nuclear medicine market over the forecast period 2012-2017. The global radiopharmaceutical market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

This report studies the global nuclear medicine market over the forecast period 2012-2017. The global radiopharmaceutical market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

This report studies the global Dental Implants & Prosthetics Market (Artificial Teeth, Dentures, and Crowns & Bridges) Current Trends, Opportunities and Global Forecasts to 2016.

The "Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component -Global Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World.

Participating hospitals reduced mortality among sepsis patents during the study period by 44 percent, 1-year poststudy mortality decreased by 54.5 percent, and the initiative has generated a positive return on investment.

The "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

The "In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017" analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Japan, BRIC and Rest of the World.

Chromatography Reagents Market By Type [Alkylation, Acylation, Solvent, Buffer], Bed Shape [Column, Thin layer], Mobile Phase [HPLC, UHPLC, HILIC, Flash, SFC], Separation Mechanism [Adsorption, Partition, Affinity] & End User - Global Forecasts to 2018, analyzes and studies the major market drivers, restraints, andopportunities in North America, Europe, Asia, and Rest of the World.

The "Vendor Neutral Archive Market & PACS Market - Global Forecast to 2018" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

In unites state, there is an about 70% of couples face this infertility problem. Infertility is a biological condition in which a female is unable to become pregnant or conceive a baby after regular and unprotected intercourse. According to a recent study, about 20% of infertility occurs due to the problems in men, 40% due to females and 30 to 40% due to problem in both men and women.

This report studies the global Dental Implants & Prosthetics Market (Artificial Teeth, Dentures, and Crowns & Bridges) Current Trends, Opportunities and Global Forecasts to 2016.

Creative Animodel developing some animodels after researching disease in human bodies. Our scientists are researching over a year in different diseases and biological conditions of human daises and introducing some species to experiment over it by injecting and removing foreign biological materials. All the models helping medical science a lot to improve further studied over it.

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

For clinical trial management services we provide a powerful end-to-end service, efficiency and quality data for every study

For clinical trial management services we provide a powerful end-to-end service, efficiency and quality data for every study

Cardiology, angioplasty and stent news and commentary. (Attached to Angioplasty.Org, the web's top noncommercial angioplasty site for patients and professionals since 1997, so it's a legitimate expert source.)